PACS COO Jergensen sells 40K shares at ~$43

PACS Group’s President & COO executed pre-planned open-market sales totaling 40,000 shares under a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) reported that President & COO Joshua Jergensen sold a total of 40,000 shares of common stock on September 16, 2026 in open-market transactions. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

The transactions consisted of 36,502 shares at a weighted average price of $43.0814 per share, with trade prices ranging from $42.57 to $43.565, and 3,498 shares at a weighted average price of $43.6181 per share, with trade prices ranging from $43.575 to $43.75.

Insider Trade Summary 10b5-1

Net Seller: 40,000 shares

Net Sell 2 txns

Insider Jergensen Joshua

Role President & COO

Sold 40,000 shs ($1.73M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	36,502	$43.0814	$1.57M
Sale	Common Stock F1, F3	3,498	$43.6181	$153K

Holdings After Transaction: Common Stock — 2,496,320 shares (Direct)

Footnotes (3)

1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
2. F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.57 to $43.565 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.575 to $43.75 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold (larger tranche): 36,502 shares Shares sold (smaller tranche): 3,498 shares Total shares sold: 40,000 shares +2 more

5 metrics

Shares sold (larger tranche) 36,502 shares Common stock sold on September 16, 2026 at a weighted average price

Shares sold (smaller tranche) 3,498 shares Common stock sold on September 16, 2026 at a weighted average price

Total shares sold 40,000 shares Aggregate common stock sales by President & COO reported in this Form 4

Weighted average price (36,502-share sale) $43.0814 per share Trades ranged from $42.57 to $43.565 on September 16, 2026

Weighted average price (3,498-share sale) $43.6181 per share Trades ranged from $43.575 to $43.75 on September 16, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PACS Group (PACS) disclose for Joshua Jergensen?

PACS Group disclosed that President & COO Joshua Jergensen sold 40,000 shares of common stock on September 16, 2026 in open-market transactions under a Rule 10b5-1 trading plan.

At what prices were the PACS shares sold in this Form 4 filing?

The filing reports weighted average prices of $43.0814 for 36,502 shares and $43.6181 for 3,498 shares. Individual trades occurred in ranges of $42.57–$43.565 and $43.575–$43.75 per share, respectively.

How many PACS (PACS) shares did Joshua Jergensen sell in each transaction?

Joshua Jergensen sold 36,502 shares of PACS common stock in one transaction and 3,498 shares in a second transaction, for a total of 40,000 shares sold on September 16, 2026.

Was the PACS insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted by Joshua Jergensen on March 12, 2026, indicating the trades were pre-arranged.

Does the PACS Form 4 state Joshua Jergensen’s holdings after the sale?

No. The Form 4 transactions list the shares sold but do not state a specific number of PACS shares held by Joshua Jergensen following these sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 06:02 PM Accepted by SEC EDGAR 09/17/2026 - 06:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jergensen Joshua

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2026		S(1)		36,502	D	$43.0814(2)	2,499,818	D
Common Stock	09/16/2026		S(1)		3,498	D	$43.6181(3)	2,496,320	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.57 to $43.565 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.575 to $43.75 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)